許繼電氣(000400.SZ):收購山東電子100%股權事項已支付全部股權轉讓款3.61億元
格隆匯5月28日丨許繼電氣(000400.SZ)公佈,公司於2020年5月20日召開八屆七次董事會審議通過了《關於現金收購中電裝備山東電子有限公司100%股權暨關聯交易的議案》,同意公司以評估價格3.61億元收購公司控股股東許繼集團所持山東電子100%股權。
近日,公司與許繼集團簽訂了《許繼集團有限公司與許繼電氣股份有限公司關於中電裝備山東電子有限公司之股權轉讓協議》並完成了全部股權轉讓款3.61億元的支付。目前公司與許繼集團正在按規定辦理山東電子的股權交割工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.